Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4042900013 | Pralsetinib only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4042901012 | Product containing only pralsetinib (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2871171000001113 | Pralsetinib (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2871181000001110 | Pralsetinib | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pralsetinib | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Pralsetinib | Is a | Product containing pralsetinib (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Pralsetinib | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Pralsetinib | Has active ingredient | Pralsetinib | true | Inferred relationship | Existential restriction modifier | 1 | |
| Pralsetinib | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only pralsetinib in oral dose form (medicinal product form) | Is a | True | Pralsetinib | Inferred relationship | Existential restriction modifier | |
| Pralsetinib 100mg capsules | Is a | True | Pralsetinib | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR